NIHON CHOUZAI CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,512 JPY | -0.72% |
|
-1.18% | +8.08% |
| Sales 2024 * | 339B 2.19B | Sales 2025 * | 354B 2.28B | Capitalization | 45.24B 292M |
|---|---|---|---|---|---|
| Net income 2024 * | 4.48B 28.9M | Net income 2025 * | 4.9B 31.63M | EV / Sales 2024 * | 0.23 x |
| Net Debt 2024 * | 31.17B 201M | Net Debt 2025 * | 26.53B 171M | EV / Sales 2025 * | 0.2 x |
| P/E ratio 2024 * |
10.1
x | P/E ratio 2025 * |
9.22
x | Employees | - |
| Yield 2024 * |
1.65% | Yield 2025 * |
1.65% | Free-Float | 29.98% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.72% | ||
| 1 week | -1.18% | ||
| Current month | -4.55% | ||
| 1 month | -6.84% | ||
| 3 months | +7.31% | ||
| 6 months | +10.69% | ||
| Current year | +8.08% |
1 week
1 487.00
1 553.00
1 month
1 487.001 645.00
Current year
1 372.001 690.00
1 year
1 080.001 690.00
3 years
1 080.001 895.00
5 years
1 080.002 080.00
10 years
647.753 212.50
| Managers | Title | Age | Since |
|---|---|---|---|
Yuhiro Inoue
PSD | President | - | - |
Kazunori Ogi
DFI | Director of Finance/CFO | 57 | 08-04-30 |
Yoshiki Kamada
DFI | Director of Finance/CFO | 74 | 12-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yosuke Mitsuhara
PSD | President | 48 | 14-05-31 |
| Director/Board Member | 61 | 90-06-30 | |
Naoto Kasai
BRD | Director/Board Member | 61 | 13-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.08% | 10 M€ | +9.51% | ||
| 0.00% | 18 M€ | +16.15% | - | |
| 0.00% | 20,721 M€ | +14.49% | - | |
| 0.00% | 66,066 M€ | +15.66% | - | |
| 0.00% | 144,586 M€ | +15.56% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 1,512 | -0.72% | 38 000 |
| 24-04-23 | 1,523 | +0.20% | 17,300 |
| 24-04-22 | 1,520 | +0.86% | 30,800 |
| 24-04-19 | 1,507 | -2.40% | 44,500 |
| 24-04-18 | 1,544 | +1.31% | 22,600 |
Delayed Quote Japan Exchange, April 24, 2024 at 02:00 am EDT
More quotes
NIHON CHOUZAI Co., Ltd is primarily engaged in the pharmacy business, the provision of staffing services, as well as the manufacture and sale of pharmaceutical products. The Company operates in three business segments. The Pharmacy segment is engaged in the operation of a chain of dispensing pharmacies. The Pharmaceutical Product Manufacturing and Distribution segment is engaged in the manufacture and nationwide sale of generic pharmaceutical products. The Healthcare Personnel Staffing Service segment is involved in the dispatching of pharmacists to various regional pharmacies.
Sector
Drug Retailers
Calendar
2024-04-29
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
1,512
JPY
Average target price
1,503
JPY
Spread / Average Target
-0.57%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.08% | 294M | |
| -15.58% | 8.35B | |
| +34.44% | 1.35B | |
| +7.12% | 428M | |
| +13.33% | 230M | |
| -10.09% | 84.32M | |
| -45.17% | 84.64M | |
| +19.97% | 59.71M |
- Stock Market
- Equities
- 3341 Stock
